United States · FDA National Drug Code directory

Carbidopa and Levodopa

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
72162-2193_9a6f3234-915f-4872-b0dc-f780eec4bfa5
Product NDC
72162-2193
Form
TABLET, EXTENDED RELEASE
Composition / generic term
Carbidopa and Levodopa
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20211005
Source listing expiry
20271231

Source-listed ingredients

  • CARBIDOPA — 50 mg/1
  • LEVODOPA — 200 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2193-1) · 72162-2193-1

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →